The Efficacy and Safety of Primalan (Mequitasine) in the Treatment of Chronic Recurrent Urticaria
Fathi Al-Ballali, Omran Bugrein & Iman Amghaiab · Asian Journal of Research in Medical and Pharmaceutical Sciences · 2018
Objective: To assess the effect of Primalan (mequitazine) in the treatment of chronic recurrent urticaria. Patients and Methods: Twenty four males (57%) and eighteen females (43%) (between ages 22-64 years) were selected, the mean age was 38 years. The disease duration was (4-12...
Open access
Research Article
10.9734/AJRIMPS/2018/41871